NASDAQ: GERN
Geron Corp Stock

$1.11+0.06 (+5.71%)
Updated Jan 24, 2022
GERN Price
$1.11
Fair Value Price
N/A
Market Cap
$357.36M
52 Week Low
$0.99
52 Week High
$2.36
P/E
-3.26x
P/B
2.36x
P/S
1,118.21x
PEG
N/A
Dividend Yield
N/A
Revenue
$403.00k
Earnings
-$107.88M
Gross Margin
100%
Operating Margin
-25,940.94%
Profit Margin
-26,769.7%
Debt to Equity
0.51
Operating Cash Flow
-$86M
Beta
0.86
Next Earnings
Mar 9, 2022
Ex-Dividend
N/A
Next Dividend
N/A

GERN Overview

Zen Score

High
Medium
Low
Industry Average (19)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GERN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GERN is good value based on its book value relative to its share price (2.36x), compared to the US Biotechnology industry average (4.59x)
Valuation
GERN's cash and short-term investments ($176.48M) cannot cover GERN's cash burn for the next year ($86.12M), once increasing cash burn (141.7%) is accounted for
Financials
GERN's profit margin has decreased... subscribe to Premium to read more.
Financials
There are 17 more GERN due diligence checks available for Premium users.

GERN News

Valuation

GERN fair value

Fair Value of GERN stock based on Discounted Cash Flow (DCF)
Price
$1.11
Fair Value
$1.14
Undervalued by
2.48%

GERN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.26x
Industry
20.6x
Market
34.17x

GERN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.36x
Industry
4.59x
GERN is good value based... subscribe to Premium to read more.
Valuation

GERN's financial health

Profit margin

Revenue
$109.0k
Net Income
-$26.7M
Profit Margin
-24,492.7%
GERN's cash and short-term investments... subscribe to Premium to read more.
Financials
GERN's profit margin has decreased... subscribe to Premium to read more.
Financials

Assets to liabilities

Assets
$229.1M
Liabilities
$77.5M
Debt to equity
0.51
GERN's short-term assets ($179.36M) exceed... subscribe to Premium to read more.
Financials
GERN's short-term assets ($179.36M) exceed... subscribe to Premium to read more.
Financials
GERN's debt has increased relative... subscribe to Premium to read more.
Financials
GERN's debt to equity ratio... subscribe to Premium to read more.
Financials

Cash flow

Operating
-$22.8M
Investing
-$5.4M
Financing
$0.0
GERN's cash and short-term investments... subscribe to Premium to read more.
Financials

Geron Corp Stock FAQ

What is Geron Corp's quote symbol?

(NASDAQ: GERN) Geron Corp trades on the NASDAQ under the ticker symbol GERN. Geron Corp stock quotes can also be displayed as NASDAQ: GERN.

What is the 52 week high and low for Geron Corp (NASDAQ: GERN)?

(NASDAQ: GERN) Geron Corp's 52-week high was $2.36, and its 52-week low was $0.99. It is currently -52.87% from its 52-week high and 12.12% from its 52-week low.

How much is Geron Corp stock worth today?

(NASDAQ: GERN) Geron Corp currently has 321,949,041 outstanding shares. With Geron Corp stock trading at $1.11 per share, the total value of Geron Corp stock (market capitalization) is $357.36M.

Geron Corp stock was originally listed at a price of $8.25 in Dec 31, 1997. If you had invested in Geron Corp stock at $8.25, your return over the last 24 years would have been -86.55%, for an annualized return of -8.02% (not including any dividends or dividend reinvestments).

How much is Geron Corp's stock price per share?

(NASDAQ: GERN) Geron Corp stock price per share is $1.11 today (as of Jan 24, 2022).

What is Geron Corp's Market Cap?

(NASDAQ: GERN) Geron Corp's market cap is $357.36M, as of Jan 25, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Geron Corp's market cap is calculated by multiplying GERN's current stock price of $1.11 by GERN's total outstanding shares of 321,949,041.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.